Population-based analysis of the impact and generalizability of the NSABP-B24 study on endocrine therapy for patients with ductal carcinomain situof the breast

Effect of low-dose tamoxifen after surgical excision of ductal intraepithelial neoplasia: results of a large retrospective monoinstitutional cohort study

(2013) A. Guerrieri-Gonzaga et al.   ANNALS OF ONCOLOGY

Reply to O.R. Colegio et al

(2013) Johan W. de Fijter et al.   JOURNAL OF CLINICAL ONCOLOGY

Prescription refill, patient self-report and physician report in assessing adherence to oral endocrine therapy in early breast cancer patients: a retrospective cohort study in Catalonia, Spain

(2012) R Font et al.   BRITISH JOURNAL OF CANCER

Adjuvant Tamoxifen Reduces Subsequent Breast Cancer in Women With Estrogen Receptor–Positive Ductal Carcinoma in Situ: A Study Based on NSABP Protocol B-24

(2012) D. Craig Allred et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

(2010) Jack Cuzick et al.   LANCET ONCOLOGY

Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer

(2008) C McCowan et al.   BRITISH JOURNAL OF CANCER

Adherence to Initial Adjuvant Anastrozole Therapy Among Women With Early-Stage Breast Cancer

(2008) Ann H. Partridge et al.   JOURNAL OF CLINICAL ONCOLOGY

Mortality Impact of Less-than-Standard Therapy in Older Breast Cancer Patients

(2007) Marianne Ulcickas Yood et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS